These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3980324)

  • 1. Two compartment kinetic model with multiple artificial capillary units.
    Blaser J; Stone BB; Zinner SH
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():131-7. PubMed ID: 3980324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives.
    Blaser J
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():125-30. PubMed ID: 3980323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro models in the study of antibiotic therapy of infections in neutropenic patients.
    Zinner SH; Blaser J
    Am J Med; 1986 May; 80(5C):40-4. PubMed ID: 3717188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro model for the study of the concentration kinetics of antibiotic combinations and their antibacterial activity].
    Patsch R; Koester G; Sandow D; Bretschneider M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):512-21. PubMed ID: 3541460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible approaches to the simulation of antibiotic kinetics and the determination of antibacterial activity in vitro.
    Tosch W; Schnell R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():117-20. PubMed ID: 3980322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an in-vitro kinetic model to study antibiotic combinations.
    Zinner SH; Blaser J; Stone BB; Groner MC
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():221-6. PubMed ID: 3920181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages and disadvantages of an in-vitro model with two compartments connected by a dialyser: results of experiments with ciprofloxacin.
    Reeves DS
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():159-67. PubMed ID: 3156839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous simulation of two different concentration time curves in vitro.
    Shah PM
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():261-4. PubMed ID: 3856564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An artificial capillary in vitro kinetic model of antibiotic bactericidal activity.
    Zinner SH; Husson M; Klastersky J
    J Infect Dis; 1981 Dec; 144(6):583-7. PubMed ID: 6799585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro model to simulate multiple drugs with distinct elimination half-lives.
    Hudson CS; Smith JE; Eales BM; Nikolaou M; Tam VH
    Int J Antimicrob Agents; 2023 Oct; 62(4):106924. PubMed ID: 37433386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding].
    Brion N; Contrepois A; Carbon C
    Presse Med; 1983 Feb; 12(5):293-6. PubMed ID: 6220387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General principles of antibiotic tissue penetration.
    Barza M; Cuchural G
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():59-75. PubMed ID: 3980337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of pharmacokinetics in the design of fixed-ratio antibiotic combinations.
    Brumfitt W; Hamilton-Miller JM
    G Ital Chemioter; 1979; 26(1-2):407-12. PubMed ID: 400152
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility testing of Haemophilus parainfluenzae by a kinetic killing-curve method.
    Jemsek JG; Martin RR; Greenberg SB; Gentry LO
    J Infect Dis; 1980 Mar; 141(3):310-6. PubMed ID: 6444977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic concentration in kidney cell fractions].
    Fujita K
    Hinyokika Kiyo; 1984 Jul; 30(7):953-6. PubMed ID: 6507212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of human extravascular temocillin concentrations simulated in an in-vitro kinetic model against beta-lactamase producing gram-negative bacilli.
    Cooper CE; White AR; Slocombe B
    J Antimicrob Chemother; 1991 Jan; 27(1):105-15. PubMed ID: 2050587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of antibiotics in children].
    Gavend M; Bessard G
    Arch Fr Pediatr; 1976; 33(7):693-703. PubMed ID: 999441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model.
    Dalhoff A
    Infection; 2005 Dec; 33 Suppl 2():44-9. PubMed ID: 16518711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo simulation of human pharmacokinetics in the rabbit.
    Bugnon D; Potel G; Caillon J; Baron D; Drugeon HB; Feigel P; Kergueris MF
    Bull Math Biol; 1998 May; 60(3):545-67. PubMed ID: 9608855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kill kinetics and regrowth pattern of bacteria exposed to antibiotic concentrations simulating those observed in vivo.
    Guggenbichler JP; Semenitz E; König P
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():139-46. PubMed ID: 3980325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.